Barclays Maintains Overweight on Nutrien, Lowers Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer maintains an Overweight rating on Nutrien (NYSE:NTR) but lowers the price target from $68 to $55.

August 16, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays analyst Benjamin Theurer maintains an Overweight rating on Nutrien but lowers the price target from $68 to $55.
The maintenance of an Overweight rating is positive, but the significant reduction in the price target from $68 to $55 suggests a more cautious outlook, likely leading to short-term downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100